A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
Premier identified opportunities for Congressional and Administrative involvement in AI governance.
Early diagnosis of CKD and optimal management by following evidence-based medicine and guidelines may increase the chance of slowing disease progression and preventing severe outcomes.
St. Luke's University Health Network teamed up with Premier's HCC Advisory Services team for guidance on how to improve HCC coding accuracy.
Premier’s AI Roadmap supports the responsible development and implementation of AI tools across the healthcare industry.
Premier submitted comments to CMS on the design of a potential new episode-based payment model aimed at improving care, lowering costs and increasing care coordination.
Premier supports FDA's draft guidance, which will provide much-needed clarity into the implementation of decentralized and hybrid clinical trials.
Premier applauds the introduction of legislation to support providers' efforts to advance value-based care.
Life sciences organizations are critical partners to help support health equity from clinical trial diversity to real-world use of therapies for all populations.
OncLive |
CAR T-cell therapies transformed the treatment landscape of multiple hematologic malignancies, but they're associated with a high cost, both for the patient and healthcare institution.
PINC AI™ data shows, while Parkinson’s patients aren’t coming to the hospital for PD specific treatment, they're coming for complications of PD treatment.
Alzheimer’s Disease poses challenges for clinicians, caregivers and patients around timely diagnosis and care coordination.
CaringWays is collaborating with PINC AI™ Applied Sciences and Premier’s Strategic Collaboratives teams to advance health equity.